Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: innovation – Page 201

Anti-cancer virus fits tumor receptor like a ‘key in a lock’

Seneca Valley virus sounds like the last bug you’d want to catch, but it could be the next breakthrough cancer therapy. Now, scientists at the Okinawa Institute of Science and Technology (OIST) and the University of Otago have described exactly how the virus interacts with tumors—and why it leaves healthy tissues alone.

The study, published in the Proceedings of the National Academy of Sciences on October 29, 2018, provides the first detailed images of how the complex Seneca Valley forms with its preferred receptor. The researchers used cryo-electron microscopy to capture images of over 7000 particles and rendered the structure in high resolution. They predict their results will help scientists develop the virus, and other viral drug candidates, for clinical use.

“If you have a virus that targets cancer cells and nothing else, that’s the ultimate cancer fighting tool,” said Prof. Matthias Wolf, principal investigator of the Molecular Cryo-Electron Microscopy Unit at OIST and co-senior author of the study. “I expect this study will lead to efforts to design viruses for .”

Major breakthrough in quest for cancer vaccine

The idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove exactly how such a vaccine would work.

Now, a team of researchers at the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal has demonstrated that a vaccine can work. Not only that, it could become an extremely effective, non-invasive and cost-effective -fighting tool.

The team’s work was published yesterday in Science Translational Medicine.

Bioquark — Electroceuticals — Real Bodies

Stefania De Matteo of HealthQe at Real Bodies Milan giving an overview of some of the new bio-physical tools (https://www.youtube.com/watch?v=HwPANPNRY4g) being developed for a 2019 biotech world
With major pharma companies like GSK entering the “electro-ceuticals” space (and groups like RegenerAge Clinic beginning to utilize them in combinatorial protocols) we are seeing a re-emergence of these century old principles back into the mainstream bio-medical discussion
I suggest everyone acquire a copy of Dr. Richard Funk’s paper “Electromagnetic effects — From cell biology to medicine” to familiarize themselves with these topics, and how they will become a synergistic part of integrated solutions for human regeneration, disease reversion, and age reversal — https://www.researchgate.net/publication/23938298_Electromag…_medicine/

NASA Announces New Partnerships for Commercial Lunar Payload Delivery

We are making tangible progress in America’s return to the Moon’s surface to stay. The innovation of America’s aerospace companies, wedded with our goals in science and human exploration are going to help us achieve amazing things on the Moon and feed forward to Mars.

Nine U.S. companies now are eligible to bid on NASA delivery services to the lunar surface through Commercial Lunar Payload Services (CLPS) contracts, as one of the first steps toward long-term scientific study and human exploration of the Moon and eventually Mars.

These companies will be able to bid on delivering science and technology payloads for NASA, including payload integration and operations, launching from Earth and landing on the surface of the Moon. NASA expects to be one of many customers that will use these commercial landing services.

“Today’s announcement marks tangible progress in America’s return to the Moon’s surface to stay,” said NASA Administrator Jim Bridenstine. “The innovation of America’s aerospace companies, wedded with our big goals in science and human exploration, are going to help us achieve amazing things on the Moon and feed forward to Mars.”

‘Solar Gravity Lens’ Could Bring Exoplanets into Sharp Focus

An innovative deep-space concept that relies on a solar gravity lens (SGL) to enable enhanced viewing of exoplanets is under study by researchers at NASA’s Jet Propulsion Laboratory (JPL) and The Aerospace Corporation.

The SGL would provide 100-billion-fold optical magnification, allowing it to show details as small as 6 miles (10 kilometers) across — similar to being able to spot something the size of New York City on an exoplanet, study team members said.

As detailed in a press statement from The Aerospace Corporation, according to Einstein’s theory of relativity, light traveling through space will bend if it passes near sufficiently massive objects. This means that distant light will bend around the periphery of the sun, eventually converging toward a focal region as if it had passed through a lens. [13 Ways to Hunt Intelligent Aliens].